25 Mg Eltrombopag Olamine Tablets

Get a Price/Quote

MOQ : 1 Vial

25 Mg Eltrombopag Olamine Tablets Specification

Pacakaging (Quantity Per Box)
10 tablets per box (common presentation)

Indication
Thrombocytopenia in patients with chronic immune thrombocytopenic purpura (ITP), hepatitis C-associated thrombocytopenia

Origin of Medicine
Allopathic

Salt Composition
Eltrombopag Olamine 25 mg

Dosage Form
Tablet

Drug Type
Prescription

Ingredients
Eltrombopag Olamine

Physical Form
Tablets

Function
Increases platelet count in blood

Recommended For
Treatment of thrombocytopenia and chronic immune thrombocytopenic purpura (ITP)

Dosage
25 mg once daily or as directed by physician

Dosage Guidelines
Take as per the physicians prescription, do not exceed recommended dose

Suitable For
Adults and pediatric patients as prescribed

Quantity
Varies, typically 7 or 14 tablets per pack

Storage Instructions
Store below 30C, protect from moisture and light

About 25 Mg Eltrombopag Olamine Tablets

Utilise the exceptional offer of 25 mg Eltrombopag Olamine Tablets-a rare, cost-effective solution designed to increase platelet counts. These astonishing, light yellow to yellow round tablets are perfect for adults and pediatric patients battling chronic immune thrombocytopenic purpura (ITP) and hepatitis C-associated thrombocytopenia. Manufactured under strict WHO-GMP and GMP standards, they ensure high quality and efficacy. Given exclusively by prescription, this uncommon medication is film-coated for ease of administration and offers a shelf life of 24 to 36 months. Always consult your healthcare provider before use during pregnancy or lactation.

Application and Usage of 25 Mg Eltrombopag Olamine Tablets

These film-coated tablets are specifically utilised for the treatment of thrombocytopenia, especially in cases of chronic immune thrombocytopenic purpura (ITP) and hepatitis C-associated thrombocytopenia. Administered orally, they are suitable for both adults and pediatric patients as prescribed, typically at a dosage of 25 mg once daily. The application areas include hospitals, specialty clinics, and through authorised pharmaceutical distributors, providing targeted therapy for patients with unusually low platelet counts.

Export Details and Certification for Eltrombopag Olamine Tablets

Dispatching Eltrombopag Olamine Tablets is conducted via major Indian FOB ports, ensuring swift delivery worldwide. With WHO-GMP and GMP certifications, quality is uncompromised from every batch dispatched. The quotation for bulk orders is provided upon request, reflecting a competitive outlay. Sample policy may be discussed with the exporter, ensuring assurance before commitment. Timely delivery and assured compliance distinguish the export process, catering to trusted distributors, exporters, suppliers, and traders.

FAQ's of 25 Mg Eltrombopag Olamine Tablets:

Q: How should 25 mg Eltrombopag Olamine Tablets be used?

A: Take one tablet orally once daily, or as directed by your physician. Do not exceed the recommended dose and always follow your healthcare provider's prescription guidelines.

Q: What conditions are these tablets indicated for?

A: Eltrombopag Olamine Tablets are primarily indicated for thrombocytopenia in patients with chronic immune thrombocytopenic purpura (ITP) and for hepatitis C-related thrombocytopenia.

Q: When should I consult a doctor before using this medication?

A: Consult your doctor before use, especially if you are pregnant, planning pregnancy, or breastfeeding, as usage must be carefully evaluated in these situations.

Q: What are the common side effects of Eltrombopag Olamine Tablets?

A: Common side effects include headache, nausea, diarrhea, and an increase in liver enzymes. Notify your healthcare provider if you experience any unusual or severe reactions.

Q: Where can I source Eltrombopag Olamine Tablets?

A: These tablets are available through licensed pharmaceutical distributors, exporters, and suppliers. They are available by prescription only and sourced from WHO-GMP certified manufacturers.

Q: What is the benefit of using these tablets?

A: The main benefit is a significant increase in platelet count, reducing the risk of bleeding in patients with chronic ITP or hepatitis C-associated thrombocytopenia.

Tell us about your requirement